Classical pathway complement activity in Familial Mediterranean fever

Clinical Biochemistry

Volumn 39, Issue 7, 2006, Pages 688-691

  Mkrtchyan, G M ^a   Boyajyan, A S ^a   Ayvazyan, A A ^b   Beglaryan, A A ^c  

^a INSTITUTE OF MOLECULAR BIOLOGY   (Armenia)

^b YEREVAN STATE MEDICAL UNIVERSITY   (Armenia)

^c the Ministry of Health of Armenia   (Armenia)

Author keywords

Colchicine; Complement system; Familial Mediterranean fever

Indexed keywords

COLCHICINE; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4;

ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HEMOLYSIS; HUMAN; IMMUNOREACTIVITY; MALE; MEASUREMENT; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; SERUM; TREATMENT DURATION;

ADULT; COLCHICINE; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT SYSTEM PROTEINS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HEMOLYSIS; HUMANS; MALE; REFERENCE VALUES; TREATMENT OUTCOME;

EID: 33745835438     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.02.016     Document Type: Article

References (22)

1. Medlej-Hashim M., Loiselet J., Lefranc G., and Megarbane A. Familial Mediterranean fever (FMF): from diagnosis to treatment. Sante 14 4 (2004) 261-266
2. Grateau G. Auto-inflammatory syndromes. Rev. Prat. 55 4 (2005) 353-359
3. Schaner P.E., and Gumucio D.L. Familial Mediterranean fever in the post-genomic era: how an ancient disease is providing new insights into inflammatory pathways. Curr. Drug Targets Inflamm. Allergy 4 1 (2005) 67-76
4. VanOss C.J. The Human Complement System in Health and Disease (1998), Marcel Dekker. Inc., New York
5. Morgan B.P. Measurement of complement hemolytic activity, generation of complement-depleted sera, and production of hemolytic intermediates. In: Morgan B.P. (Ed). Methods in Molecular Biology. Complement Methods and Protocols (2000), Humana Press, Totowa, NJ 61-71
6. Mollnes T.E., Song W.-C., and Lambris J.D. Complement in inflammatory tissue damage and disease. Trends Immunol. Today 23 2 (2002) 61-66
7. Holers V.M. The complement system as a therapeutic target in autoimmunity. Clin. Immunol. 107 3 (2003) 140-151
8. Ayesh S.K., Azar Y., Babior B.M., and Matzner Y. Inactivation of interleukin-8 by the CSa-inactivating protease from serosal fluid. Blood 81 6 (1993) 1424-1427
9. Matzner Y., Abedat S., and Shapiro E. et al. Expression of the familial Mediterranean fever gene and activity of the C5a inhibitor in human primary fibroblast cultures. Blood 96 2 (2000) 727-731
10. Notarnicola C., Didelot M.N., Seguret F., Demaille J., and Touitou I. Enhanced cytokine mRNA levels in attack-free patients with familial Mediterranean fever. Genes Immun. 3 1 (2002) 43-45
11. Akcan Y., Bayraktar Y., Arslan S., VanThiel D.H., Zerrin B.C., and Yildiz O. The importance of serial measurements of cytokine levels for the evaluation of their role in pathogenesis in familial Mediterranean fever. Eur. J. Med. Res. 8 7 (2003) 304-306
12. Baykal Y., Saglam K., Yilmaz M.I., Taslipinar A., Akinci S.B., and Inal A. Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin. Rheumatol. 22 2 (2003) 99-101
13. Mkrtchyan G.M., Boyajyan A.S., Karageuzyan K.G., Ayvazyan A.A., Pashinyan S.H., and Nazaretyan E.Ye. Protein composition of circulating immune complexes in patients with Periodic disease complicated or not complicated by renal amyloidosis. Dokl. Biol. Sci. 385 (2002) 329-330
14. Korkmaz C., Özdogan H., Kasapçopur Ö., and Yazici H. Acute phase response in familial Mediterranean fever. Ann. Rheumatol. Dis. 61 (2002) 79-81
15. Odabas A.R., Cetinkaya R., Selcuk Y., Keles S., and Bilen H. Serum C-reactive protein levels during attack-free periods of familial Mediterranean fever. Pain Clin. 13 4 (2002) 319-321
16. Schwabe A.D., Terasaki P.I., Batnett E.V., Territo M.C., Klinenberg J.R., and Peters R.S. Familial Mediterranean fever: recent advances in pathogenesis and management. West J. Med. 127 (1977) 15-23
17. Ollier-Hartmann M.-P., Godeau P., Gouet E., and Hartmann L. Le systeme du complement dans la maladie periodique. Ann. Med. Interne 132 7 (1981) 467-471
18. Wautier J.-L., Mosesson M., Dervichian M., and Cattan D. Complement serique et cryofibinogene dans la maladie periodique. Ann Med Interne 132 7 (1981) 472-474
19. Reimann H.A., Coppola E.D., and Villegas G.R. Serum complement defects in periodic diseases. Ann. Intern. Med. 73 (1970) 737-740
20. Livneh A., Langevitz P., Zemer D., Zaks N., Kees S., and Lidar T. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 40 (1997) 1879-1885
21. Whaley K., and North J. Haemolytic assays for whole complement activity and individual components. In: Doods A.W., and Sim R.B. (Eds). Complement. A Practical Approach, (1997), Oxford Univ. Press, Oxford 19-47
22. Daha M.R. Purification of complement component. In: Doods A.W., and Sim R.B. (Eds). Complement. A Practical Approach (1997), Oxford Univ. Press, Oxford 121-133